Srinivas Sridhar

Papers

Total Citations

168

H-Index

About

Srinivas Sridhar is a leading figure in nanomedicine and cancer therapy, with a particular focus on developing nanoparticle-based platforms for targeted radiotherapy. His major contributions lie at the intersection of materials science and oncology, where he has pioneered the use of gold nanoparticles to enhance radiation dose delivery to tumors while minimizing damage to healthy tissue. His highly cited 2014 work, “Targeted Radiotherapy with Gold Nanoparticles,” has garnered 168 citations and remains a foundational reference in the field, outlining both current capabilities and future directions for this precision approach. Sridhar’s research has significantly advanced the clinical translation of nanotherapeutics, demonstrating how engineered particles can be functionalized with targeting ligands and radiosensitizers to improve treatment outcomes. His work is widely recognized for bridging fundamental nanomaterial design with practical therapeutic applications, influencing subsequent studies in image-guided therapy and theranostics. With an extensive publication record and sustained citation impact, Sridhar continues to shape the landscape of nanoparticle-mediated cancer treatment, making his research essential reading for students and scientists working at the frontier of radiation oncology and nanobiotechnology.